Science

Shai Shimony: Biology and Management of NPM1 Mutated AML

Shai Shimony/apfmed.org

Feb 7, 2025, 08:42

Shai Shimony: Biology and Management of NPM1 Mutated AML

Shai Shimony, Advanced Clinical Fellow at Dana-Farber Cancer Institute, shared an article by Evan C. Chen, et al. on X:

“A comprehensive, up-to-date and clinically relevant review on NPM1-mutated AMLsm. Led by Evan Chen, Marlise R. Luskin and Richard Stone, this is trully a clinical pearl for clinicians.”

Biology and Management of Acute Myeloid Leukemia With Mutated NPM1.

Authors: Evan C. Chen, et al.

Shai Shimony: Biology and Management of NPM1 Mutated AML

Acute Myeloid Leukemia AML biology cancer Dana-Farber Cancer Institute Evan C. Chen Evan Chen fight against cancer Global fight against cancer Marlise R. Luskin NPM1 OncoDaily Oncology Richard Stone Shai Shimony

Global Health Dialogues with Princess Dina Mired | Episode 1: Dr. Firas Al-Hawari

NEW PAPER ALERT: ESOPEC trial on Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer

Oncologist Near Me - Matti Aapro: Pioneering Excellence in Cancer Care and Geriatric Oncology

World Cancer Day: 25 Years of Global Action and Unity in the Fight Against Cancer

Oncologist Near Me – Giuseppe Curigliano: A Prominent Specialist in Breast Cancer Clinical Trials and Research